Literature DB >> 22750547

Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Folkert Steinhagen1, Corinna Meyer, Debra Tross, Mayda Gursel, Takahiro Maeda, Sven Klaschik, Dennis M Klinman.   

Abstract

Synthetic ODNs expressing CpG motifs trigger an innate immune response via TLR9. pDCs are major effectors of this response. Two structurally distinct classes of CpG ODNs have been identified that differentially activate pDCs. "K" ODNs trigger the production of TNF-α and IL-6, whereas "D" ODNs preferentially induce the secretion of IFN-α. As K and D ODNs have distinct therapeutic effects, knowledge of their shared and sequence-specific activity is of considerable importance. This work uses the CAL-1 human pDC line to analyze the effect of CpG stimulation on gene expression. Genes up-regulated by both K and D ODNs (n=92) were largely dependent on type I IFN signaling and characterized functionally by antiviral activity. K ODNs induced a short-term increase in IFN-α/β production and uniquely up-regulated genes that supported antibacterial responses. In contrast, D ODNs triggered a persistent increase in IFN-α/β production and uniquely up-regulated genes associated with metabolic functions. Thus, the core functionality of human pDCs mediated by TLR9 ligation rests on a type I IFN response that differs from the response induced by the structural elements unique to specific classes of ODNs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750547      PMCID: PMC3441315          DOI: 10.1189/jlb.1011522

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response.

Authors:  H Weighardt; C Feterowski; M Veit; M Rump; H Wagner; B Holzmann
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 4.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

5.  CXCL16 influences the nature and specificity of CpG-induced immune activation.

Authors:  Mayda Gursel; Ihsan Gursel; Howard S Mostowski; Dennis M Klinman
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

6.  Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs.

Authors:  D Verthelyi; K J Ishii; M Gursel; F Takeshita; D M Klinman
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

7.  Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.

Authors:  M Hijikata; Y Ohta; S Mishiro
Journal:  Intervirology       Date:  2000       Impact factor: 1.763

8.  Short- and long-term changes in gene expression mediated by the activation of TLR9.

Authors:  Sven Klaschik; Debra Tross; Hidekazu Shirota; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-12-14       Impact factor: 4.407

9.  A random variance model for detection of differential gene expression in small microarray experiments.

Authors:  George W Wright; Richard M Simon
Journal:  Bioinformatics       Date:  2003-12-12       Impact factor: 6.937

10.  Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006.

Authors:  Atsushi Kato; Toshiki Homma; Jonathan Batchelor; Noriko Hashimoto; Shosuke Imai; Hiroshi Wakiguchi; Hirohisa Saito; Kenji Matsumoto
Journal:  BMC Immunol       Date:  2003-07-30       Impact factor: 3.615

View more
  10 in total

1.  Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic Cells.

Authors:  Tae Whan Kim; Seunghee Hong; Yin Lin; Elise Murat; HyeMee Joo; Taeil Kim; Virginia Pascual; Yong-Jun Liu
Journal:  J Immunol       Date:  2016-09-14       Impact factor: 5.422

2.  Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.

Authors:  Melanie R Neeland; Martin J Elhay; David R Powell; Fernando J Rossello; Els N T Meeusen; Michael J de Veer
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

3.  Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA.

Authors:  Jorge L Cervantes; Esther Oak; John Garcia; Hongfei Liu; Paolo A Lorenzini; Deepika Batra; Arvind Chhabra; Juan C Salazar; Xavier Roca
Journal:  Tuberculosis (Edinb)       Date:  2019-05-03       Impact factor: 3.131

Review 4.  DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori.

Authors:  Matthew Gordon Varga; Richard M Peek
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

5.  Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.

Authors:  Christian Bode; Mario Fox; Poonam Tewary; Almut Steinhagen; Richard K Ellerkmann; Dennis Klinman; Georg Baumgarten; Veit Hornung; Folkert Steinhagen
Journal:  Eur J Immunol       Date:  2016-05-27       Impact factor: 5.532

6.  Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation.

Authors:  Marco Cardone; Amiran K Dzutsev; Hongchuan Li; Nicolas Riteau; Franca Gerosa; Kevin Shenderov; Robin Winkler-Pickett; Lisa Provezza; Elena Riboldi; Robert M Leighty; Selinda J Orr; Folkert Steinhagen; Mark D Wewers; Alan Sher; Stephen K Anderson; Romina Goldszmid; Daniel W McVicar; Lyudmila Lyakh; Giorgio Trinchieri
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells.

Authors:  Alexis Combes; Voahirana Camosseto; Prudence N'Guessan; Rafael J Argüello; Julie Mussard; Christophe Caux; Nathalie Bendriss-Vermare; Philippe Pierre; Evelina Gatti
Journal:  Nat Commun       Date:  2017-10-13       Impact factor: 14.919

8.  Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.

Authors:  Kwan T Chow; Courtney Wilkins; Miwako Narita; Richard Green; Megan Knoll; Yueh-Ming Loo; Michael Gale
Journal:  J Immunol       Date:  2018-10-08       Impact factor: 5.426

9.  Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.

Authors:  Taiki Aoshi; Yasunari Haseda; Kouji Kobiyama; Hirotaka Narita; Hideaki Sato; Hirokazu Nankai; Shinichi Mochizuki; Kazuo Sakurai; Yuko Katakai; Yasuhiro Yasutomi; Etsushi Kuroda; Cevayir Coban; Ken J Ishii
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

10.  Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1.

Authors:  Tobias Hilbert; Folkert Steinhagen; Christina Weisheit; Georg Baumgarten; Andreas Hoeft; Sven Klaschik
Journal:  Mediators Inflamm       Date:  2015-12-06       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.